- FDA Approves New Medication for Chronic Weight ManagementFDA.gov
- FDA approves Eli Lilly’s diabetes drug Mounjaro for obesity under new name, ZepboundCNN
- FDA approves Eli Lilly’s tirzepatide for weight loss, paving way for wider use of blockbuster drugCNBC
- FDA approves Mounjaro for weight lossFOX 32 Chicago
- FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to Ozempic and WegovyNBC News
- View Full Coverage on Google News